Top compounds associated with response to CCDC144NL


Feature Type Standardized
Nominal ANOVA
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.026 0.5
mRNA PD318088 CTRPv2 pan-cancer AAC 0.025 0.5
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.026 0.5
mRNA MI-1 CTRPv2 pan-cancer AAC 0.028 0.5
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.026 0.5
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.022 0.5
mRNA ciclosporin CTRPv2 pan-cancer AAC -0.026 0.5
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.024 0.5
mRNA BRD8899 CTRPv2 pan-cancer AAC 0.026 0.5
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC -0.023 0.5
Download CSV